MedTrace Logo

Evaluate the Effectiveness of Self-care Multifaceted Strategy in Heart Failure Patients

NCT04062461 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 704

Last updated 2023-03-02

No results posted yet for this study

Summary

Study Design: A randomized, multicenter, national, phase II clinical trial aimed at evaluating the effectiveness of self-care promotion using a multifaceted strategy based on sending text messages(SMS)to patients with heart failure.

Methodological quality:

* Central randomization with allocation concealment;
* Decision committee for blind outcome assessment;
* Intention-to-treat analysis

Conditions

Interventions

OTHER

Multifaceted strategy based on sending text messages(SMS)

multifaceted strategy based on sending text messages(SMS) to patients with heart failure. Press educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity). The text messages are about how the patient should take your drugs (evem diuretics), measure blood pressure and weight in Kg, and about signals and symptoms (shorthbreathness during the night), and about how important is practice physical exercises and don't drink alcohol.

OTHER

Usual outpatient care

Educational content on heart failure for the patient (symptoms of the disease, healthy habits for HF, warning signs for severity)

Sponsors & Collaborators

  • Hospital Moinhos de Vento

    collaborator OTHER

  • Hospital do Coracao

    lead OTHER

Principal Investigators

  • Félix J Alvarez Ramires, Alvarez Ramires · Hospital do Coração - HCor

  • Luiz E Rohde, MD,PhD · Hospital Moinhos de Vento

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-08
Primary Completion
2023-01-06
Completion
2023-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04062461 on ClinicalTrials.gov